US 9072716
Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells
granted A61KA61K31/00A61K38/164
Quick answer
US patent 9072716 (Methods of treating and preventing inflammatory bowel disease involving IL-13 and NKT cells) held by The United States of America, as represented by the Secretary Department of Health by Human Servies expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary Department of Health by Human Servies
- Grant date
- Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/00, A61K38/164, A61K38/2086, A61P